Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin 4 mg versus simvastatin 40 mg in primary hypercholesterolemia or combined dyslipidemia
2005-001037-15Phase 3Completed
- Sponsor
- Kowa Research Europe
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pitavastatin and simvastatin in hypercholesterolemia and combined dyslipidaemia (2 arms), sponsored by Kowa Research Europe. Primary endpoint: Non-inferiority for LDL-C reduction. Started May 2005; status: completed.
02
Drugs
pitavastatinsimvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on 2005-001037-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001037-15.